1 The National Institute of Neurological Disorders and

Stroke rt-PA Stroke Study Group. Tissue plasminogen

activator for acute ischemic stroke[J]. N Engl J Med，

1995，333：1581-1587.

2 Hacke W，Kaste M，Bluhmki E，et al. Thrombolysis

with alteplase 3 to 4.5 hours after acute ischemic

stroke[J]. N Engl J Med，2008，359：1317-1329.

3 Berkhemer OA，Fransen PS，Beumer D，et al. A

randomized trial of intraarterial treatment for acute

ischemic stroke[J]. N Engl J Med，2015，372：11-20.

4 Saver JL，Goyal M，Bonafe A，et al. Stent-retriever

thrombectomy after intravenous t-PA vs . t-PA alone in

stroke[J]. N Engl J Med，2015，372：2285-2295.

5 Campbel l BC，Mitchel l PJ，Kleinig TJ，et al.

Endovascular therapy for ischemic stroke with

perfusion-imaging selection[J]. N Engl J Med，2015，

372：1009-1018.

6 Liao XL，Wang CX，Wang YL，et al. Implementation

and outcome of thrombolysis with alteplase 3 to

4.5 h after acute stroke in Chinese patients[J]. CNS

Neurosci Ther，2013，19：43-47.

7 Liao X，Wang Y，Pan Y，et al. Standard-dose

intravenous tissue-type plasminogen activator for stroke

is better than low doses[J]. Stroke，2014，45：2354-2358.

8 Tomsick T，Broder ick J，Ca r rozel la J，e t a l .

Revascularization results in the Interventional

Management of Stroke Ⅱ trial[J]. AJNR Am J

Neuroradiol，2008，29：582-587.

9 Wa h lg r en N，Ahmed N，Dáva l o s A，e t a l .

Thrombolysis with alteplase for acute ischaemic stroke

in the Safe Implementation of Thrombolysis in Stroke-

Monitoring Study (SITS-MOST)：an observational

study[J]. Lancet，2007，369：275-282.

10 Hacke W，Kaste M，Fieschi C，et al. Randomised

double-blind placebo-controlled trial of thrombolytic

therapy with intravenous alteplase in acute ischaemic

stroke (ECASS Ⅱ). Second European-Australasian

Acute Stroke Study Investigators[J]. Lancet，1998，

352：1245-1251.

11 Khar itonova T，Mi kuli k R，Roine RO，e t a l.

Association of early National Institutes of Health

Stroke Scale improvement with vessel recanalization

and functional outcome after intravenous thrombolysis

in ischemic stroke[J]. Stroke，2011，42：1638-1643.

12 Wunderlich MT，Goer tler M，Poster t T，et al.

Recanalization after intravenous thrombolysis：does

a recanalization time window exist?[J]. Neurology，

2007，68：1364-1368.

13 Khar itonova TV，Melo TP，Andersen G，et al.

Importance of cerebral artery recanalization in patients

with stroke with and without neurological improvement

after intravenous thrombolysis[J]. Stroke，2013，44：

2513-2518.

14 Mullen MT，Pisapia JM，Tilwa S，et al. Systematic

review of outcome after ischemic stroke due to

anterior circulation occlusion treated with intravenous，

intra-arterial，or combined intravenous + intra-arterial

thrombolysis[J]. Stroke，2012，43：2350-2355.

15 Mok i n M，Kass-Hout T，Kass-Hout O，e t a l.

Intravenous thrombolysis and endovascular therapy

for acute ischemic stroke with internal carotid artery

occlusion：a systematic review of clinical outcomes[J].

Stroke，2012，43：2362-2368.

16 De Silva DA，Brekenfeld C，Ebinger M，et al. The

benefits of intravenous thrombolysis relate to the

site of baseline arterial occlusion in the Echoplanar

Imaging Thrombolytic Evaluation Trial (EPITHET)[J].

Stroke，2010，41：295-299.

17 Bhatia R，Hill MD，Shobha N，et al. Low rates of

acute recanalization with intravenous recombinant

tissue plasminogen activator in ischemic stroke：realworld

experience and a call for action[J]. Stroke，2010，

41：2254-2258.